STELA: Correlation of Ultrasonographic Lesion Type Characterization With Angioplasty Outcomes in Failing Dialysis AVFs

Sponsor
Attikon Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06119100
Collaborator
(none)
200
1
51
3.9

Study Details

Study Description

Brief Summary

The continuous increase in the incidence of end stage renal disease and hemodialysis patients, has raised the interest of the vascular access scientific community and many researchers are currently investigating the potential mechanisms of arteriovenous fistulas (AVF) dysfunction. Roy-Chaudhury et al. were the first to suggest neointimal hyperplasia (NIH) as the main reason of AVF dysfunction and vessel negative remodeling as another important factor. First, Yamamoto et al. described 3 stenotic lesions categories of arteriovenous grafts (AVG) observed by ultrasonography: 1. vascular constriction type, 2. neointimal hyperplasia type, 3. mixed type (constriction and neointimal hyperplastic type).

The main goals of this prospective observetional study are:
  • The characterization of AVF stenotic lesions by ultrasonography

  • The correlation of the stenotic lesion type with the outcomes of percutaneous transluminal angioplasty and the rate of reintervention.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Ultrasound characterization of stenotic lesion type

Detailed Description

This is a prospective, observetional study designed to investigate the correlation of stenotic lesion type characterization (1. vascular constriction type, 2. neointimal hyperplasia type, 3. mixed type eg. constriction and neointimal hyperplastic type) using Duplex ultrasound, with the outcomes of high pressure plain balloon angioplasty. In total 200 patients with failing dialysis arteriovenoyus fistula (AVF) scheduled to undergo angioplasty of stenotic lesion(s) will be included. The study's primary endpoint will be the correlation between stenotic lesion type and target lesion re-intervention due to clinical recurrence at 6 months follow up.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Characterization of STEnotic Lesion Type of Haemodialysis Arteriovenous Fistulae by Ultrasonography and Correlation With the Outcomes of Percutaneous Transluminal Angioplasty
Actual Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Correlation of target lesion reintervention (TLR) due to clinical recurrence and lesion type [6 months]

    The correlation of the speciific lesion type classified based on the pre-procedural ultrasonographic assessment and the target lesion reintervention rate due to clinical recurrence, will be investigated

  2. Lesion characterization [Less than 48 hours before the procedure]

    Lesion type will be classified as restrictive, hyperplastic or mixed based on the pre-procedural Duplex ultrasound assessment and the rates of each type will be recorded.

Secondary Outcome Measures

  1. Restenosis characterization post angioplasty [6 months]

    restenosis type will be classified as restrictive, hyperplastic or mixed based on the 6 months Duplex ultrasound assessment and the rates of each type will be recorded.

  2. AVF survival [6 months]

    The overall AVF survival (secondary patency) will be recorded.

  3. Binary restenosis rate [6 months]

    Binary (>50%) restenosis detected using Duplex ultrasound.

  4. Periprocedural complication rate [Up to 48 hours post-procedure]

    Procedure related complications rate

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patiens with failing AVF scheduled to undergo fluoroscopically-guided high-pressure balloon angioplasty

  • Signed study concent form

Exclusion Criteria:
  • Patients undergoing dialysis via arteriovenous graft (AVG)

  • Contraindications to angioplasty

  • Immature AVF

Contacts and Locations

Locations

Site City State Country Postal Code
1 "Attikon" University General Hospital Athens Attiki Greece 12461

Sponsors and Collaborators

  • Attikon Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stavros Spiliopoulos, Associate Professor of Diagnostic and Interventional Radiology, Attikon Hospital
ClinicalTrials.gov Identifier:
NCT06119100
Other Study ID Numbers:
  • 77758
First Posted:
Nov 7, 2023
Last Update Posted:
Nov 7, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Stavros Spiliopoulos, Associate Professor of Diagnostic and Interventional Radiology, Attikon Hospital

Study Results

No Results Posted as of Nov 7, 2023